A team of proven experts in strategy, program management, and operations, we know how to generate valid evidence far more efficiently than industry norms. We are led by Partners, who have, in prior roles, led the industry in biopharmaceutical R&D productivity, as ranked by the CNBC RQ 50. We have codified methods to ensure that the firms we invest in can create the necessary systems, and make highly efficient competitive, human, financial, design and communications choices.